• Español
  • English
  • facebook
  • twitter
  • rss
  • Español
  • English
  • facebook
  • twitter
  • rss
TNI D&D
  • Inicio
  • Quiénes
    somos
    • Quiénes somos
    • Personas
    • Partners
    • Investigadores
    • Datos de contacto
    • En la prensa
    • Newsletter
  • Sala de Prensa
    • Contactos de prensa
    • Comunicados de prensa
    • Recursos
    • Últimas noticias
  • Temas
    • Debate sobre políticas de drogas en las Américas
    • Descriminalización
    • Proporcionalidad de las penas
    • Reducción de daños
    • Reclasificación de sustancias
    • Consumo de crack más seguro
    • Derechos humanos
    • Regulación
    • Desclasificación de la hoja de coca
    • Fracaso de la guerra a las drogas
    • Dessarollo alternativo
    • Cannabis
    • Productores
    • Law enforcement
    • ATS, Mild stimulants & NPS
    • European Drug Policy
    • Lavado de dinero
  • Control
    de drogas
    • Convenciones
    • ONUDD
    • CdE
    • JIFE
    • UNGASS
  • Información
    por país
    • Mapa de la región
    • América Central
      • El Salvador
      • Guatemala
      • Honduras
      • Costa Rica
    • América Latina
      • Argentina
      • Bolivia
      • Paraguay
      • Brasil
      • Chile
      • Colombia
      • Ecuador
      • Perú
      • Uruguay
      • Venezuela
    • México
    • Caribbean
      • Jamaica
      • Belize
    • Afghanistan
  • Eventos
    • Seminarios de expertos
    • Diálogos Informales sobre Drogas
    • Eventos publicos
    • Magistrados proponen reforma
  • Publicaciones
    • Informes sobre políticas de drogas
    • Reformas a las leyes de drogas
    • Serie reforma legislativa
    • El rostro humano
    • Drugs & conflict
    • Drogas y Derecho (CEDD)
      • Sistemas sobrecargados
    • Mercados de drogas y violencia
  • Weblog

 

Summary of report Beckley Foundation

‘Licensing and Regulation of the Cannabis Market in England and Wales: Towards A Cost Benefit Analysis’

The Beckley report, Licensing and Regulation of the Cannabis Market in England and Wales: Towards a Cost-Benefit Analysis, grasps of the economic consequences of a regulated market, as opposed to the current prohibitionist model. This is essential for evaluating the impacts of possible drug policy reform. The report outlines the factors which must be included in further cost-benefit analyses. The report costed 60.000 pounds and 3 years to create. Reliable data was often lacking and more evidence is needed.

One of the key advantages to a cost-benefit analysis is its complete elimination of subjective and emotive processes, which have become an unfortunate mainstay in the drug policy debate - this gives the results an objective credibility.

It is very important to note that by excluding 'internal costs and benefits' the report specifically excludes the reasons why people use cannabis, such as medication, enjoyment and creativity - instead this report takes the perspective of a concerned tax payer, or a budget-focused politician.

An often-used argument surrounding cannabis reform is the concept of the 'gateway effect'; the idea that cannabis use leads to the use of 'harder drugs'. This report not only rejects the idea of a demand side gateway effect (through a thorough assessment of the available data), but also introduces the idea that a regulated market would virtually eliminate another sort of damaging gateway effect, namely the supply-side gateway. This is where social dealers of cannabis come into contact with professional dealers of a larger variety of drugs and thus are more likely to progress to dealing harder drugs.

Another element which has gained much attention in recent history is the mental health costs of cannabis brought about by the increased ratio of THC to CBD. One of the many advantages of a regulated market is that through health-education, labelling and variable tax rates, strains of cannabis with a high CBD ratio can be encouraged, particularly for vulnerable users.

The main conclusion is that there would be a net social benefit to reform of some­where between 280 and 460 million pounds. This means that even when we ignore the experiential benefits claimed by cannabis users and just focus on the financial effects on society at large, the argument for reform remains robust, compelling and increasingly difficult for policy makers to ignore.

On top of the financial benefit there are of course many other advantages. These include increased respect of human rights, the avoidance of discrimination in the enforcement of prohibition, the minimisation of the blighting effect of a criminal record on a person’s life and the increased accessibility to health information and treatment. The current criminalization of cannabis users sacrifices the credibility of health campaigns. Moreover, based on US evidence it is expected that access to cannabis for teenagers would probably decrease.

Because taxes are a transfer, rather than a net social gain, they are not included in the report’s cost benefit analysis. However, a conservative estimation is made of what the tax revenue might be following reform.

The authors aim to bring the price of cannabis to lower than the illicit price, whilst aiming to keep it high enough to deter the expansion of use due to low price, particularly by the young. This would be achieved by a tax rate of around 70%, which is lower than the 83% on cigarettes and closer to the 72% on high alcohol beer.

The report predicts a small increase in cannabis quantity [+15% - +40%] due to a decreased cannabis price. The price elasticity of cannabis is estimated between [-0.2, -0.7]. The cross-price elasticity is important to consider: will alcohol consumption decrease if the price of cannabis decreases and cannabis consumption increases? According to a study of Clements and Zhao (2005), a4% increase in cannabis consumption would lead to a decrease of alcohol consumption (-1% beer, -2% wine, -4% spirits).

The authors assumed a cap on THC levels of 10% for licensed cannabis. By creating this limitation it leaves higher THC strains of cannabis in the illicit market. It would probably be better to keep all strains of cannabis within the licit market, and use taxation intelligently to make more potentially risky or harmful strains of cannabis less financially attractive. Campaigns could move users away from combining tobacco and cannabis.

The authors estimate that the government would gain in budgetary terms by something around one billion pounds a year, roughly three quarters of which would come from tax revenues rather than expenditure savings. In these times of economic hardship cost-benefit analyses with positive results should surely begin to play a key role in government.

The report

Mark Bryan, Emilia Del Bono, Stephen Pudney, Licensing and Regulation of the Cannabis Market in England and Wales: Towards a Cost-Benefit Analysis, Institute for Social and Economic Research (Iser), University of Essex & Beckley Foundation, September 2013

  • Labels
    teen use | teorí­a de entrada | reino unido | regulación | cannabis

Últimas noticias

  • Los clubes de cannabis de Barcelona preparan una demanda millonaria contra el Ayuntamiento por su cierre
    12.01.2024
  • Sanidad retomará desde este mes la regulación del cannabis medicinal
    01.01.2024
  • El Ayuntamiento de Barcelona estrecha el cerco sobre los clubes de cannabis y busca la manera de cerrarlos todos
    31.12.2023
  • Las tiendas de cannabis en Nueva York generan 150 millones de dólares en su primer año
    29.12.2023
  • Pionera, pero no perfecta: 10 años de la legislación del cannabis de uso adulto en Uruguay
    25.12.2023
  • Países Bajos experimenta con la venta de cannabis cultivado legalmente en el país
    15.12.2023
Más noticias

Weblog

    Ceguera deliberada: La JIFE no encuentra nada bueno que decir sobre legalización 
del cannabis
    14.03.2023
Más weblog

Destacados

El equilibrio entre la estabilidad y el cambio

La modificación inter se de los tratados de fiscalización de drogas de la ONU para facilitar la regulación del cannabis


Vasos comunicantes...

vasos hilite2

Derechos humanos, cultivo ilícito y desarrollo alternativo


Amapola, opio y heroína

La producción de Colombia y México


Marruecos y el cannabis

Reducción, contención o aceptación


Tags

revisión de 10 años  26 UNGASS 1998  7 debate CND 2005  5 UNGASS 2016  75 2019 HLM  1 activism  10 afganistán  8 show all

Tags

revisión de 10 años  26 UNGASS 1998  7 debate CND 2005  5 UNGASS 2016  75 2019 HLM  1 activism  10 afganistán  8 hide
albania  2 desarrollo alternativo  135 amnesty  17 amsterdam  4 argentina  209 ETA  7 australia  5 ayahuasca  1 referendo 2012  33 sistema bancario  31 bélgica  14 belize  1 bermuda  2 bolivia  261 brasil  195 doctrina brownfield  12 birmania  11 california  54 canadá  87 cannabinoides  33 cannabis  1793 clubes de cannabis  510 industria del cannabis  103 el caribe  12 caricom  4 américa central  7 chile  85 china  4 sociedad civil  27 CND  92 coca  475 cocaína  50 coffee shop  64 declive cognitivo  5 colombia  501 colorado  25 internamiento obligatorio  46 conflict  2 convenciones  241 corporate capture  4 corruption  1 costa rica  9 pasta base  98 crimen  43 república checa  14 decertification  2 descriminalización  747 deforestation  2 dinamarca  13 drug checking  3 salas de consumo  57 tribunales de drogas  16 mercados de drogas  71 drug testing  2 drug tourism  1 tráfico de drogas  44 éxtasis  12 ecuador  63 egipto  2 el salvador  6 environment  8 erradicación  184 medicamentos esenciales  5 política de drogas europea  44 grupo consultivo de expertos  3 ejecuciones extrajudiciales  9 fair trade  3 fentanilo  5 francia  70 fumigación  50 teorí­a de entrada  6 alemania  47 comisión global  44 grecia  4 guatemala  40 iniciativa de guatemala  56 reducción de daños  184 cáñamo  7 heroína  17 tratamiento asistido con heroína  15 VIH/SIDA  41 autocultivo  209 honduras  5 derechos humanos  108 encarcelación  48 JIFE  122 india  5 diálogos informales sobre drogas  19 inter se modification  5 israel  10 italia  13 jamaica  20 ketamina  4 khat  5 kratom  5 debate américa latina  195 cumplimiento de la ley  169 líbano  4 euforizantes legales  11 legalización  876 luxembourg  17 malta  5 marihuana medicinal  300 metanfetamina  3 méxico  362 estimulantes ligeros  12 lavado de dinero  28 marruecos  86 naloxone  1 holanda  91 new york  8 nueva zelanda  6 noruega  1 NPS  3 encuesta de opinión  47 opioides  10 opio  51 oregón  6 panama  1 paraguay  19 patentes  1 paz  72 perú  98 peyote  1 filipinas  5 pilot project  31 policía pacificadora  15 portugal  59 prevención  2 situación carcelaria  124 prohibicíon  68 proporcionalidad  102 psychedelics  2 psicosis  7 puerto rico  1 reclasificación  52 recriminalización  45 regulación  987 rusia  3 sacramental use  1 safe supply  1 crack más seguro  37 scheduling  14 scientific research  8 sdg  2 seguridad  19 imposición de penas  54 social justice  21 sudáfrica  1 españa  476 san vicente y las granadinas  1 tratamiento de sustitución  29 suiza  66 tributación  25 tailandia  3 cantidades umbral  56 productores  79 tramadol  1 tratamiento  7 túnez  5 reino unido  16 control de drogas ONU  373 UNGASS  57 UNODC  68 uruguay  517 política de drogas estadounidense  305 venezuela  5 violencia  107 OMS  36 informe mundial sobre drogas  8

Este sitio web

UN Drug Control

In 2011 the 1961 UN Single Convention on drugs will be in place for 50 years. In 2012 the international drug control system will exist 100 years since the International Opium Convention was signed in 1912 in The Hague. Does it still serve its purpose or is a reform of the UN Drug Conventions needed? This site provides critical background.

Drug Law Reform on the map

dlronthemap_und

Copyright © 2024 Drug Law Reform in Latin America

Website by WebWolf